Invion Ltd (IVX) - Total Assets

Latest as of June 2025: AU$9.49 Million AUD ≈ $6.71 Million USD

Based on the latest financial reports, Invion Ltd (IVX) holds total assets worth AU$9.49 Million AUD (≈ $6.71 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See IVX book value for net asset value and shareholders' equity analysis.

Invion Ltd - Total Assets Trend (2001–2025)

This chart illustrates how Invion Ltd's total assets have evolved over time, based on quarterly financial data.

Invion Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Invion Ltd's total assets of AU$9.49 Million consist of 9.8% current assets and 90.2% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	9.0%
Accounts Receivable	AU$0.00	0.0%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$0.00	0.0%
Intangible Assets	AU$8.54 Million	90.0%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2001–2025)

This chart illustrates how Invion Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see IVX market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Invion Ltd's current assets represent 9.8% of total assets in 2025, an increase from 0.0% in 2001.
Cash Position: Cash and equivalents constituted 9.0% of total assets in 2025, up from 0.0% in 2001.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 89.0% of total assets, an increase from 77.0% in 2001.
Asset Diversification: The largest asset category is intangible assets at 90.0% of total assets.

Invion Ltd Competitors by Total Assets

Key competitors of Invion Ltd based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr67.43 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Regencell Bioscience Holdings Ltd NASDAQ:RGC	USA	$5.76 Million
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Henan Newland Pharmaceutical Co. Ltd. A SHE:301277	China	CN¥1.77 Billion

Invion Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.75	2.05	2.81
Quick Ratio	0.75	3.25	2.81
Cash Ratio	0.69	0.77	0.00
Working Capital	AU$-304.96K	AU$1.07 Million	AU$590.04K

Invion Ltd - Advanced Valuation Insights

This section examines the relationship between Invion Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.88
Latest Market Cap to Assets Ratio	0.39
Asset Growth Rate (YoY)	-38.6%
Total Assets	AU$9.49 Million
Market Capitalization	$3.70 Million USD

Valuation Analysis

Below Book Valuation: The market values Invion Ltd's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Invion Ltd's assets decreased by 38.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Invion Ltd (2001–2025)

The table below shows the annual total assets of Invion Ltd from 2001 to 2025.

Year	Total Assets	Change
2025-06-30	AU$9.49 Million ≈ $6.71 Million	-38.59%
2024-06-30	AU$15.45 Million ≈ $10.93 Million	-18.88%
2023-06-30	AU$19.05 Million ≈ $13.48 Million	-4.96%
2022-06-30	AU$20.04 Million ≈ $14.18 Million	+255.20%
2021-06-30	AU$5.64 Million ≈ $3.99 Million	-2.06%
2020-06-30	AU$5.76 Million ≈ $4.08 Million	-4.97%
2019-06-30	AU$6.06 Million ≈ $4.29 Million	-41.42%
2018-06-30	AU$10.35 Million ≈ $7.32 Million	+78.06%
2017-06-30	AU$5.81 Million ≈ $4.11 Million	-51.49%
2016-06-30	AU$11.98 Million ≈ $8.48 Million	-25.57%
2015-06-30	AU$16.10 Million ≈ $11.39 Million	+9.29%
2014-06-30	AU$14.73 Million ≈ $10.42 Million	-9.35%
2013-06-30	AU$16.25 Million ≈ $11.50 Million	+137.96%
2012-06-30	AU$6.83 Million ≈ $4.83 Million	+44.38%
2011-06-30	AU$4.73 Million ≈ $3.35 Million	+5.39%
2010-06-30	AU$4.49 Million ≈ $3.18 Million	-81.55%
2009-06-30	AU$24.32 Million ≈ $17.21 Million	+650.97%
2008-06-30	AU$3.24 Million ≈ $2.29 Million	-13.32%
2007-06-30	AU$3.74 Million ≈ $2.64 Million	-73.22%
2006-06-30	AU$13.95 Million ≈ $9.87 Million	+2.24%
2005-06-30	AU$13.64 Million ≈ $9.65 Million	+439.85%
2004-06-30	AU$2.53 Million ≈ $1.79 Million	+22.43%
2003-06-30	AU$2.06 Million ≈ $1.46 Million	+39.18%
2002-06-30	AU$1.48 Million ≈ $1.05 Million	+2.77%
2001-06-30	AU$1.44 Million ≈ $1.02 Million	--

About Invion Ltd

AU:IVX Australia Drug Manufacturers - Specialty & Generic

Market Cap

$3.70 Million

AU$5.22 Million AUD

Market Cap Rank

#28883 Global

#1661 in Australia

Share Price

AU$0.06

Change (1 day)

-1.61%

52-Week Range

AU$0.06 - AU$0.15

All Time High

AU$4.80